Effects of the aromatase inhibitor testolactone on human benign prostatic hyperplasia
- 30 September 1987
- Vol. 50 (1-3), 191-200
- https://doi.org/10.1016/0039-128x(83)90071-5
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Development of a model for the induction of estrogen-related prostatic hyperplasia in the dog and its response to the aromatase inhibitor 4-hydroxy-4-androstene-3,17-dione: Preliminary resultsThe Prostate, 1986
- Transrectal Ultrasonic Volume Determination of the Prostate—A Preoperative and Postoperative StudyJournal of Urology, 1982
- Inhibition of Peripheral Aromatization of Androstenedione to Estrone in Postmenopausal Women with Breast Cancer Using Δ1Testololactone*Journal of Clinical Endocrinology & Metabolism, 1979
- Conversion of Androstenedione to Estrone in Human Fibroblasts Cultured from Prostate, Genital and Nongenital SkinHormone and Metabolic Research, 1979
- Light Microscopic Stereological Analysis of the Normal Human Prostate and of Benign Prostatic HyperplasiaJournal of Urology, 1979
- Correlation among Prostate Stroma, Plasma Estrogen Levels, and Urinary Estrogen Excretion in Patients with Benign Prostatic HypertrophyJournal of Clinical Endocrinology & Metabolism, 1978
- The induction of prostatic hypertrophy in the dog with androstanediol.JCI Insight, 1976
- Recent Studies on the Mechanism of Action of TestosteroneNew England Journal of Medicine, 1972
- Medical Treatment of Benign Nodular Prostatic Hyperplasia with Cyproterone AcetateJournal of Urology, 1969
- Histological changes in the organs of rats injected with œstrone alone or simultaneously with æstrone and testicular hormoneThe Journal of Pathology and Bacteriology, 1935